One of the world’s largest wigmakers, Japan’s Unihair (formerly Aderans), is currently experimenting with new technology which could one day turn baldness into a thing of the past.
The overall aim of the research is to provide the ability to take healthy hair follicles from a patient suffering from hair loss, and then replicate them many times over in a lab. These ‘cloned’ hair cells could then be injected back into the individual’s scalp where they would grow new hair naturally.
A ‘Fundamental Shift’ in Hair Loss Treatments
Unihair’s chief executive, Tadao Otsuki, commented, “We see a tremendous number of possibilities [in the hair cell re-generation process]. It adds up to a fundamental shift in how the world can combat problems of baldness.”
While the process is still in its infancy and not yet available on the market, once refined it could prove to be the solution that hair loss sufferers the world over are looking for. In theory, it could one day be possible to re-grow a full head of hair from just a few healthy hair cells.
Unihair Acquires Hair-Cell Regeneration Research assets from Field Leaders Intercytex
Unihair’s research into the field of hair cell re-generation was bolstered in March of this year, when it acquired the scientific assets of UK based regenerative medicine specialist Intercytex, including those relating to ICX-TRC, the company’s much talked about hair regeneration therapy. Intercytex itself announced last week that it was reforming as a private enterprise and would be working with the US military to develop technology which enables skin to heal more effectively after being burnt.
In February 2009, scientists from Intercytex discussed their findings following Phase II clinical trials in hair cell regeneration technology, in the journal Future Medicine. Most notably, they concluded that, “while these systems are valuable for demonstrating the principle of hair induction, they do not provide a means to efficiently [grow] hair in the human scalp,” suggesting that it may still be some time before the prospective treatment is available to hair loss sufferers.
Leonora Doclis, senior trichologist at The Belgravia Centre said, “Cell regeneration is an exciting prospect for those who cannot benefit from the pharmaceutical regrowth treatments already available. Should the procedure be available in the future, those who never dreamed of the return to a full head of hair might have the opportunity to restore their hair back to the way it was in their youth. The comb over could be a thing of the past.”
Minoxidil and Propecia to Remain Essential in Battle against Hair Loss
If proved successful, hair cell regeneration treatment could one day render hair transplants and other hair loss remedies obsolete. It is expected though that current pharmaceutical methods of stabilising and restoring hair, such as the use of Minoxidil and Propecia, will continue to play an essential role in the fight against hair loss, and will be used in conjunction with the new treatment. Both of these formulas are currently the only such products which are scientifically proven to stimulate hair re-growth, and are licensed by the MHRA and approved by the FDA in the UK and US respectively, for the treatment of genetic hair loss.
Thankfully, if you don’t fancy waiting around to see if the new method works, the Belgravia Centre currently offers extensive treatments for a wide range of hair loss conditions. These treatments combine the use of Minoxidil and Propecia with specially formulated ‘hair growth boosters’ and close trichological monitoring to ensure that hair re-growth potential is maximised.